Join
Live feed
·
PRReleasevia Quantisnow
EyePoint Inc. logo

EyePoint Pharmaceuticals to Highlight DURAVYUTM (vorolanib intravitreal insert) Clinical and Regulatory Progress and Pipeline Innovation at R&D Day 2024

ByQuantisnow·Wall Street's wire, on your screen.
EYPT· EyePoint Inc.
Industrials

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track EYPT (EyePoint Inc.) and more on Quantisnow.